SMITH ANDREW

Role
Associate professor  
Academic disciplines
Biochemistry (BIOS-07/A)
Scientific-Disciplinary Group:
BIOCHEMISTRY (05/BIOS-07)

Publications

  • Denti, V., Greco, A., Alviano, A., Capitoli, G., Monza, N., Smith, A., et al. (2024). Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(23) [10.3390/ijms252313115]. Detail

  • Denti, V., Capitoli, G., Bindi, G., Denti, F., Smith, A. (2024). Image segmentation with Bayesian mixtures models for multiomics MSI analyses. Intervento presentato a: IMSIS 2024 – 2nd Annual Conference an Mass Spectrometry Imaging and Integrated Topics, Münster, Germany. Detail

  • Bindi, G., Monza, N., Santos de Oliveira, G., Denti, V., Palubeckaite, I., de Haan, N., et al. (2024). A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy. Intervento presentato a: The 48th FEBS Congress, Milano, Italia. Detail

  • Bindi, G., Monza, N., Santos de Oliveira, G., Denti, V., Palubeckaitė, I., de Haan, N., et al. (2024). Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication. Intervento presentato a: BMSS Imaging & MALDI SIG Meeting 2024, Sheffield, England. Detail

  • Piga, I., Magni, F., Smith, A. (2024). The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations. FEBS LETTERS, 598(6), 621-634 [10.1002/1873-3468.14795]. Detail

Research projects

Dissecting the tumour-immune landscape of ccRCC: the role of altered lipid metabolism in resistance to immunotherapy - I° annualità
Year: 2024
Grantors: FONDAZIONE AIRC
Dissecting the single-cell phenotypes in ccRCC to elucidate the mechanisms driving resistance to immunotherapy
Year: 2023
Call: FAQC 2023 - prima finestra
Grantors: Università degli Studi di MILANO-BICOCCA
Dissecting the tumour-immune landscape of ccRCC: the role of altered lipid metabolism in resistance to immunotherapy
Year: 2023
Call: Roche per la Ricerca 2023
Grantors: Fondazione Roche
A digital pathology platform for molecular onconephrology: the PROFOUND project
Year: 2021
Call: Bando della Ricerca Finalizzata 2019
Grantors: MINISTERO DELLA SALUTE